NEFL and amyotrophic lateral sclerosis: In a single-center pilot clinical study, patients treated with DFP (30 mg/kg/day) for 3 months showed improved ALS functional scores, mitigated oxidative distress, and reduced levels of cerebral iron and neurofilament light chain in the CSF.